150 related articles for article (PubMed ID: 10928482)
1. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
[TBL] [Abstract][Full Text] [Related]
2. Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass.
van den Goor JM; Nieuwland R; Rutten PM; Tijssen JG; Hau C; Sturk A; Eijsman L; de Mol BA
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1029-36. PubMed ID: 17350849
[TBL] [Abstract][Full Text] [Related]
3. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
4. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
[TBL] [Abstract][Full Text] [Related]
5. Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit.
Fabre O; Vincentelli A; Corseaux D; Juthier F; Susen S; Bauters A; Van Belle E; Mouquet F; Le Tourneau T; Decoene C; Crépin F; Prat A; Jude B
Ann Thorac Surg; 2008 Aug; 86(2):537-41. PubMed ID: 18640330
[TBL] [Abstract][Full Text] [Related]
6. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
7. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass.
Chung JH; Gikakis N; Rao AK; Drake TA; Colman RW; Edmunds LH
Circulation; 1996 Jun; 93(11):2014-8. PubMed ID: 8640976
[TBL] [Abstract][Full Text] [Related]
8. Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass.
Davidson SJ; Woodhams B
Int J Lab Hematol; 2011 Dec; 33(6):614-6. PubMed ID: 21569219
[TBL] [Abstract][Full Text] [Related]
9. Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass : relationship to increased thrombin generation and heparin concentration.
Philippou H; Davidson SJ; Mole MT; Pepper JR; Burman JF; Lane DA
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):248-54. PubMed ID: 9974404
[TBL] [Abstract][Full Text] [Related]
10. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
Asero R; Tedeschi A; Coppola R; Griffini S; Paparella P; Riboldi P; Marzano AV; Fanoni D; Cugno M
J Allergy Clin Immunol; 2007 Mar; 119(3):705-10. PubMed ID: 17204316
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
Brister SJ; Ofosu FA; Buchanan MR
Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
[TBL] [Abstract][Full Text] [Related]
12. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
[TBL] [Abstract][Full Text] [Related]
15. Involvement of tissue factor pathway inhibitor in the coronary circulation of patients with acute coronary syndromes.
Golino P; Ravera A; Ragni M; Cirillo P; Piro O; Chiariello M
Circulation; 2003 Dec; 108(23):2864-9. PubMed ID: 14656922
[TBL] [Abstract][Full Text] [Related]
16. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
17. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.
Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant actions of tissue factor pathway inhibitor on tissue-factor-dependent plasma coagulation.
Ofosu FA
Semin Thromb Hemost; 1995; 21(2):240-4. PubMed ID: 7660146
[TBL] [Abstract][Full Text] [Related]
19. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery.
Craven S; Dewar L; Yang X; Ginsberg J; Ofosu F
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):219-25. PubMed ID: 17413757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
